is auvi q fda approved?
160598
PARIS, Aug. 13, 2012 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that the U.S. Food and Drug Administration (FDA) has approved Auvi-Q (epinephrine injection, USP) for the emergency treatment of life-threatening allergic reactions in people who are at risk for or have a history of anaphylaxis.
545140
E-cigarettes, including the ones made by Juul, are not currently FDA-approved. Juul has until spring 2020 to apply for approval as a new tobacco product.
134924
Since its launch in 2013, IMBRUVICA has received 11 FDA approvals across six disease areas: chronic lymphocytic leukemia (CLL) with or without 17p deletion (del17p); small lymphocytic lymphoma (SLL) with or without del17p; Waldenström's macroglobulinemia (WM); previously-treated patients with mantle cell lymphoma (MCL ...
523340
However, on October 30, 2015, the FDA announced Sanofi's voluntary recall of the Auvi-Q. ... "The products have been found to potentially have inaccurate dosage delivery, which may include failure to deliver drug," the FDA said at the time.
1203191
Infliximab is not FDA approved for uveitis or ocular inflammation. It is currently FDA approved for Crohn's disease, ulcerative colitis, rheumatoid arthritis, psoriatic arthritis and plaque psoriasis, and ankylosing spondylitis.
1396135
EECP has been approved by the United States Food and Drug Administration (FDA) for the management of refractory angina (Class IIb). About 200 hospitals across India have adopted this technique.
716819
(NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved both VYNDAQEL® (tafamidis meglumine) and VYNDAMAX™ (tafamidis) for the treatment of the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) in adults to reduce cardiovascular mortality and ...
1304493
In the mid-1990s, the Food and Drug Administration (FDA) banned over-the-counter availability of quinine and marketing of prescription quinine products for leg cramps. In early 2007, FDA banned all prescription quinine products other than Qualaquin.
450188
Some government-sponsored health plans will provide coverage for AUVI-Q. However, coverage for those patients may vary widely. ... Patients who are eligible for Medicaid coverage may be eligible for assistance to receive AUVI-Q at no cost.
799987
Auvi-Q poses many benefits. It is smaller than an EpiPen and fits right in your pocket. It also has voice instructions, eliminating the need for manual instructions. Another benefit to Auvi-Q is that it is the first and only epinephrine auto-injector with an auto-retractable needle.
423318
Through the kaléo Cares Patient Assistance Program, patients who do not have commercial insurance and who are experiencing financial difficulties may be able to receive AUVI-Q at no cost. To be eligible for assistance, you must: Have a prescription for AUVI-Q.
1257678
At this moment, MONQ is not FDA approved because our personal essential oil diffusers fall under the category within the aromatherapy industry that does not require FDA approval. Visit MONQ.com/safety to learn more about our safety measures and research.
1205322
(NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration ( FDA ) has approved Praluent® (alirocumab) to reduce the risk of heart attack, stroke and unstable angina requiring hospitalization in adults with established cardiovascular (CV) disease.
1103084
The US Food and Drug Administration has approved two companies' applications to make generic versions of apixaban, which will be the first generic versions of any direct oral anticoagulant (DOAC) despite the drug entering the market behind two other competitors.
232934
Opdivo and Keytruda approved in new lung cancer uses. The FDA has approved Merck's Keytruda (pembrolizumab) as a combination treatment for metastatic nonsquamous non-small cell lung cancer (NSCLC), after green-lighting Bristol-Myers Squibb's (BMS) rival blockbuster Opdivo (nivolumab) for small cell lung cancer (SCLC).
1241933
Lutera and Aubra can be switched between one another and other brand names containing the same active ingredient. They are considered therapeutically equivalent by the FDA (Food and Drug Administration).
250027
Enfuvirtide is a prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of HIV infection in people whose infection is not well-controlled by ongoing treatment with other HIV medicines.